Prolonged Hypercoagulability Following Major Liver Resection for Malignancy

Conditions: Hepatic Disease; Surgery-Complications; Hypercoagulability; Thrombosis Interventions: Drug: Redesca (enoxaparin sodium for injection); Drug: Fragmin (dalteparin) Sponsors: Western University, Canada; Valeo Pharma Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials